Signaling pathways involved in postconditioning-induced cardioprotection of human myocardium, in vitro

Experimental Biology and Medicine

Volumn 235, Issue 6, 2010, Pages 768-776

  Lemoine, Sandrine ^a   Puddu, Paolo Emilio ^b   Durand, Charline ^a   Lepage, Olivier ^c   Babatasi, Gérard ^c   Ivascau, Calin ^c   Massetti, Massimo ^a,c   Gérard, Jean Louis ^a,c   Hanouz, Jean Luc ^a,c  

^a UNIVERSITÉ DE CAEN   (France)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Human myocardium; Mitochondrial adenosine triphosphate sensitive potassium channels; p38 mitogen activated protein kinase; Postconditioning; Protein kinase C

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 HYDROXYDECANOIC ACID; ANISOMYCIN; CALPHOSTIN C; DIAZOXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HEART MUSCLE; HEART PROTECTION; HUMAN; HUMAN TISSUE; HYPOXIA; MAJOR CLINICAL STUDY; MUSCLE ISOMETRIC CONTRACTION; TISSUE OXYGENATION;

HEART; HUMANS; MUSCLE STRENGTH; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHYSICAL FITNESS; POTASSIUM CHANNELS; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 77953192485     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.009342     Document Type: Article

References (53)

1. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, André-Fouët X, Ovize M. Postconditioning the human heart. Circulation 2005;112:2143-2148
2. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-88
3. Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 2006;70:308-314
4. Zatta AJ, Kin H, Lee G, Wang N, Jiang R, Lust R, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Vinten-Johansen J. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res 2006;70:315-324
5. Lemoine S, Beauchef G, Zhu L, Renard E, Lepage O, Massetti M, Khayat A, Galera P, Gérard JL, Hanouz JL. Signaling pathways involved in desflurane-induced postconditioning in human atrial myocardium in vitro. Anesthesiology 2008;109:1036-1044
6. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004;44:1103-1110
7. Mykytenko J, Reeves JG, Kin H,Wang NP, Zatta AJ, Jiang R, Guyton RA, Vinten-Johansen J, Zhao ZQ. Persistent beneficial effect of postconditioning against infarct size: role of mitochondrial K (ATP) channels during reperfusion. Basic Res Cardiol 2008;103:472-484
8. Lu J, Zang WJ, Yu XJ, Jia B, Chorvatova A, Sun L. Effects of postconditioning of adenosine and acetylcholine on the ischemic isolated rat ventricular myocytes. Eur J Pharmacol 2006;549:133-139
9. Krolikowski JG, Bienengraeber M, Weihrauch D, Warltier DC, Kersten JR, Pagel PS. Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: the role of mitochondrial KATP channels. Anesth Analg 2005;101:1590-1596
10. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 2006;70:200-211
11. Musiolik J, van Caster P, Skyschally A, Boengler K, Gres P, Schulz R, Heusch G. Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. Cardiovasc Res 2010;85:110-117
12. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, Heusch G. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 2009;104:15-18
13. Sun HY, Wang NP, Halkos M, Kerendi F, Kin H, Guyton RA, Vinten-Johansen J, Zhao ZQ. Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways. Apoptosis 2006;11:1583-1593
14. Beguin PC, Belaidi E, Godin-Ribuot D, Levy P, Ribuot C. Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and Erk1/2. J Mol Cell Cardiol 2007;42:343-351
15. Dana A, Skarli M, Papakrivopoulou J, Yellon DM. Adenosine A (1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ Res 2000;86:989-997
16. Tsukamoto O, Asanuma H, Kim J, Minamini T, Takashima S, Ogai A, Hirata A, Fujita M, Shinozaki Y, Mori H, Tomoike H, Hori M, Kitakaza M. A role of mitochondrial ATP-sensitive potassium channels in the infarct size-limiting effect of ischemic preconditioning via activation of protein kinase C in the canine heart. Biochem Biophys Res Commun 2005;338:1460-1466
17. Jaburek M, Costa ADT, Burton JR, Costa CL, Garlid KD. Mitochondrial PKC-ε and mitoKATP copurify and coreconstitute to form a functioning signalling module in proteoliposomes. Circ Res 2006;99:878-883
18. Yue Y, Qin Q, Cohen MV, Downey JM, Critz SD. The relative order of m K (ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc Res 2002;55:681-689
19. Zhao TC, Hines DS, Kukreja RC. Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K (ATP) channels. Am J Physiol Heart Circ Physiol 2001;280:H1278-85
20. Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, Heusch G. Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 2009;104:469-483
21. Hanouz JL, Massetti M, Guesne G, Chanel S, Babatasi G, Rouet R, Ducouret P, Khayat A, Galateau F, Bricard H, Gérard JL. In vitro effects of desflurane, sevoflurane, isoflurane, and halothane in isolated human right atria. Anesthesiology 2000;92:116-124
22. Loubani M, Galinanes M. Pharmacological and ischemic preconditioning of the human myocardium: mitoKATP channels are upstream and p38 MAPK is downstream of PKC. BMC Physiology 2002;2:10-23
23. Cohen MV, Yang XM, Downey JM. Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success. Basic Res Cardiol 2008;103:464-471
24. Penna C, Mancardi D, Rastaldo R, Losano G, Pagliaro P. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res 2007;75:168-177
25. Hanley PJ, Mickel M, Lffler M, Brandt U, Daut J. KATP channelin-dependent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 2002;542:735-741
26. Carroll R, Yellon DM. Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial KATP. Basic Res Cardiol 2000;95:243-249
27. Sun HY, Wang NP, Kerendi F, Halkos M, Kin H, Guyton RA, Vinten-Johansen J, Zhao ZQ. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 2005;288:H1900-8
28. Ohnuma Y, Miura T, Miki T, Tanno M, Kuno A, Tsuchida A, Shimamoto K. Opening of mitochondrial K(ATP) channel occurs downstream of PKC-epsilon activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol 2002;283:H440-7
29. Hassouna A, Matata BM, Galiñanes M. PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium. Am J Physiol Cell Physiol 2004;287:C1418-25
30. Sato T, O'Rourke B, Marbán E. Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. Circ Res 1998;83:110-114 (Pubitemid 28322105)
31. Liu H, Zhang HY, Zhu X, Shao Z, Yao Z. Preconditioning blocks cardiocyte apoptosis: role of K(ATP) channels and PKC-epsilon. Am J Physiol Heart Circ Physiol 2002;282:H1380-6
32. Wang Y, Hirai K, Ashraf M. Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ Res 1999;85:731-741 (Pubitemid 29480814)
33. Wang Y, Ashraf M. Role of protein kinase C in mitochondrial KATP channel-mediated protection against Ca2+ overload injury in rat myocardium. Circ Res 1999;84:1156-1165 (Pubitemid 29244777)
34. Wang Y, Takashi E, Xu M, Ayub A, Ashraf M. Downregulation of protein kinase C inhibits activation of mitochondrial K(ATP) channels by diazoxide. Circulation 2001;104:85-90 (Pubitemid 32623294)
35. Li RC, Ping P, Zhang J, Wead WB, Cao X, Gao J, Zheng Y, Huang S, Han J, Bolli R. PKCe modulates NF-κB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 2000;279:H1679-89
36. Ping P, Zhang J, Huang S, Cao X, Tang XL, Li RC, Zheng YT, Qiu Y, Clerk A, Sugden P, Han J, Bolli R. PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 1999;277:H1771-85
37. Ping P, Zhang J, Cao X, Li RC, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, Bolli R. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol Heart Circ Physiol 1999;276:H1468-81
38. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, Ping P. Mitochondrial PKC-epsilon and MAPK form signalling modules in the murine heart: enhanced mitochondrial PKC-epsilon MAPK interactions and differential MAPK activation in PKC-epsilon induced cardioprotection. Circ Res 2002;90:390-397
39. Baines CP, Liu GS, Birincioglu M, Critz SD, Cohen MV, Downey JM. Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton. Am J Physiol Heart Circ Physiol 1999;276:H1361-68
40. Samavati L, Monick MM, Sanlioglu S, Buettner GR, Oberley LW, Hunninghake GW. Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am J Physiol Cell Physiol 2002;283:C273-81
41. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, André-Fouët X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M. Long-term benefit of postconditioning. Circulation 2008;117:1037-1044
42. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, André-Fouët X, Revel D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008;359:473-481
43. Peart JN, Gross ER, Headrick JP, Gross GJ. Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection. J Mol Cell Cardiol 2007;42:972-980
44. Lauzier B, Delemasure S, Debin R, Collin B, Sicard P, Acar N, Bretillon L, Joffre C, Bron A, Creuzot-Garcher C, Vergely C, Rochette L. Beneficial effects of myocardial postconditioning are associated with reduced oxidative stress in a senescent mouse model. Transplantation 2008;85:1802-1808
45. Przyklenk K, Maynard M, Darling CE, Whittaker P. Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol 2008;51:1393-1398
46. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 2008;102:131-135
47. Saito W, Noguchi K, Okazaki K, Matsuda T, Kato Y, Tanaka H, Shigenobu K. Temperature-sensitive effects of potassium channel openers on isolated guinea pig myocardium and aorta. J Cardiovasc Pharmacol 1998;31:327-329
48. Clerk A, Sugden PH. The p38 MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinase/c-Jun N-terminal kinases (SPAKs/JNKs). FEBS Lett 1998;426:93-96
49. Davies SP, Reddy H, Caivano H, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105
50. Schäfer G, Wegener C, Portenhauser R, Bojanovski D. Diazoxide, an inhibitor of succinate oxidation. Biochem Pharmacol 1969;18:2678-2681
51. Lim KH, Javadov SA, Das M, Clarke SJ, Suleiman MS, Halestrap AP. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol 2002;545:961-974
52. Dow J, Bhandari A, Kloner RA. Ischemic postconditioning's benefit on reperfusion ventricular arrhythmias is maintained in the senescent heart. J Cardiovasc Pharmacol Ther 2008;13:141-148
53. Sivaraman V, Mudalgiri NR, Di C, Kolvekar S, Hayward M, Yap J, Keogh B, Hausenloy DJ, Yellon DM. Postconditioning protects human atrial muscle through the activation of the RISK pathway. Basic Res Cardiol 2007;102:453-459